— Know what they know.
Not Investment Advice

DXR NASDAQ

Daxor Corporation
1W: -3.6% 1M: -1.2% 3M: +0.8% YTD: -26.1% 1Y: -21.9% 3Y: +6.3% 5Y: +8.4%
$10.62
-0.36 (-3.28%)
 
Weekly Expected Move ±7.3%
$9 $10 $11 $11 $12
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 53 · $62.0M mcap · 3M float · 0.495% daily turnover · Short 53% of daily vol

Balance Sheet Trends

Total Assets
$46M +25.6% ▲
5Y CAGR: +22.7%
Total Liabilities
$123K -85.4% ▼
5Y CAGR: -32.5%
Shareholders Equity
$46M +28.2% ▲
5Y CAGR: +24.0%
Cash & Investments
$0 +0.0% ▲
Total Debt
$112K -84.7% ▼
5Y CAGR: -8.1%
Net Debt
$112K -84.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$711K$0$0$0$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$711K$0$0$0$0
Net Receivables$31K$17K$14K$10K$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$9K$0
Total Current Assets$764K$38K$26K$19K$0
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$24M$30M$35M$37M$46M
Other Non-Current Assets$0$0$0$0$10K
Total Non-Current Assets$24M$30M$35M$37M$46M
Total Assets$25M$30M$35M$37M$46M
— Liabilities —
Accounts Payable$87K$62K$103K$110K$0
Short-Term Debt$716K$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3K$0$0$0$0
Total Current Liabilities$806K$62K$103K$110K$0
Long-Term Debt$3M$1M$756K$730K$112K
Other Non-Current Liab.$0$0$0$0$11K
Total Non-Current Liabilities$3M$1M$756K$730K$123K
Total Liabilities$4M$1M$859K$840K$123K
— Equity —
Common Stock$53K$53K$53K$54K$55K
Retained Earnings$20M$25M$25M$26M$0
Accumulated OCI$20M$25M$0$0$35M
Total Stockholders Equity$21M$29M$34M$36M$46M
Total Liabilities & Equity$25M$30M$35M$37M$46M
— Key Metrics —
Total Debt$3M$1M$756K$730K$112K
Net Debt$2M$1M$756K$730K$112K
Total Investments$24M$30M$35M$37M$46M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms